HOW I DO IT
|Year : 2016 | Volume
| Issue : 4 | Page : 433-443
Approach to a tremor patient
Soumya Sharma, Sanjay Pandey
Department of Neurology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, India
|Date of Submission||29-Jun-2016|
|Date of Decision||29-Jul-2016|
|Date of Acceptance||29-Jul-2016|
|Date of Web Publication||21-Nov-2016|
Academic Block, Room No 507, Department of Neurology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi - 110 002
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Tremors are commonly encountered in clinical practice and are the most common movement disorders seen. It is defined as a rhythmic, involuntary oscillatory movement of a body part around one or more joints. In the majority of the population, tremor tends to be mild. They have varying etiology; hence, classifying them appropriately helps in identifying the underlying cause. Clinically, tremor is classified as occurring at rest or action. They can also be classified based on their frequency, amplitude, and body part involved. Parkinsonian tremor is the most common cause of rest tremor. Essential tremor (ET) and enhanced physiological tremor are the most common causes of action tremor. Isolated head tremor is more likely to be dystonic rather than ET. Isolated voice tremor could be considered to be a spectrum of ET. Psychogenic tremor is not a diagnosis of exclusion; rather, demonstration of various clinical signs is needed to establish the diagnosis. Severity of tremor and response to treatment can be assessed using clinical rating scales as well as using electrophysiological measurements. The treatment of tremor is symptomatic. Medications are effective in half the cases of essential hand tremor and in refractory patients; deep brain stimulation is an alternative therapy. Midline tremors benefit from botulinum toxin injections. It is also the treatment of choice in dystonic tremor and primary writing tremor.
Keywords: Botulinum toxin, deep brain stimulation, essential tremor, head tremor, Parkinson disease, tremor, tremor rating scales
|How to cite this article:|
Sharma S, Pandey S. Approach to a tremor patient. Ann Indian Acad Neurol 2016;19:433-43
| Introduction|| |
Tremor is the most common movement disorder encountered in clinical practice.  It is produced when there are alternating and synchronous contractions of reciprocally innervated agonistic and antagonistic muscles that cause a symmetrical displacement about the midpoint of the movement in both the directions.  Tremor is seen in nearly 5% of the population over the age of 40 years.  The most common tremors in clinical practice are enhanced physiological tremor, essential tremor (ET), and Parkinsonian rest tremor. , These tremors tend to occur more commonly in the older population. Despite its high prevalence, symptoms tend to be mild in the majority of patients and a very small proportion actually seeks medical attention. In patients who present to a clinician, the tremor could be disabling. Hence, a systematic approach is needed to classify the tremor and identify the underlying etiology. Once the cause of the tremor is established, appropriate treatment can be started.
| Classification|| |
Although tremors can be classified in several ways, the most important parameter used is the occurrence of tremor in relation to movement or position of a body part. Based on this, they are classified as rest or action tremor [Figure 1]. , Action tremor is further classified into postural or kinetic tremor. When the tremor worsens on approaching a target, it is classified as intention tremor, which is considered to be a type of kinetic tremor. This distinction helps in identifying underlying pathophysiology and etiology, which in turn aids in the management. Tremor can also be classified based on its frequency, amplitude, anatomical distribution, exacerbating or alleviating factors, and associated neurological signs [Table 1]. ,,,,
|Table 1: Classification of tremor according to frequency, amplitude, and body part involvement characteristics|
Click here to view
| Tremor Syndromes|| |
Rest tremor is characteristically present when the involved extremity is completely supported against gravity. They subside when the involved limb is put into action.
The most common cause of rest tremor is Parkinson's disease (PD).  There are three tremor syndromes associated with PD. , These are the classical rest tremor or rest plus postural/kinetic tremor of same frequency (re-emergent tremor), second is the rest plus postural/kinetic tremor of differing frequencies with the latter having a higher frequency (5-8 Hz), and third isolated postural and kinetic tremor with a frequency of 4-9 Hz.
The typical tremor of PD is a 4-6 Hz rest tremor. It is characteristically unilateral at onset and involves the distal upper extremity initially. The classical "pill rolling" tremor consists of movement at the thumb and forefinger, giving the appearance as though the patient is trying to roll something in between these fingers. Rest tremor could also be in the form of flexion - extension of the wrist, pronation - supination at the forearm, and abduction - adduction of leg. , Rest tremor in PD not only involves hands but also involves lips, chin, jaw, and legs and rarely the neck, head, or voice which are seen more commonly with ET. 
The "re-emergent" tremor appears after an interval of few seconds (range 1-47 s vs. a latency of 0 s in ET) of maintaining the arm in front and it has a similar frequency as that of a rest tremor.  Some patients with PD may have an associated or an isolated action tremor. This action tremor is responsible for the motor disability in PD rather than the more common rest tremor. 
Other causes of rest tremor
When a patient presents with rest tremor, it is natural to assume that the patient has PD, even more so if the tremor is asymmetrical. However, it is important to remember that there are a few other causes of rest tremor, which have been highlighted in [Figure 1]. ,, Certain patients develop only a rest tremor, which persists beyond 2 years without development of other cardinal signs of PD [Figure 1]. , The term "monosymptomatic rest tremor (mRT)" has been used to describe these patients. Majority of these patients are diagnosed as PD by functional imaging. In the minority, however, there is no presynaptic dopaminergic deficit and these cases are diagnosed as scans without evidence of dopaminergic deficits (SWEDDs).  A higher score on the motor examination of Unified Parkinson Disease Rating Scale and difficulty with gait, posture, and stance favor a diagnosis of PD, whereas the presence of bilateral tremor is more often a feature of SWEDDs. Furthermore, the amplitude of tremor may help determine the cause of the mRT with highest amplitude of rest tremor seen with PD while patients with SWEDDs, dystonic tremor, and ET have the highest amplitude during action. 
Parkinsonian syndromes other than PD such as multisystem atrophy, progressive supranuclear palsy, and corticobasal degeneration are important causes of rest tremor [Figure 1]. Certain drugs, which have dopamine receptor-blocking property, can also produce rest tremor. These drugs include antipsychotics, antiemetics (metoclopramide), and antivertigo medications (prochlorperazine). ,, Certain nondopamine receptor-blocking drugs can also produce rest tremor. These are valproate, calcium channel blockers (cinnarizine, flunarizine), selective serotonin reuptake inhibitors, lithium, tetrabenazine, and amiodarone [Figure 1]. ,,
Action tremor occurs when a limb is voluntarily contracting. It is subdivided into postural, kinetic, and isometric tremor. Action tremors make up the largest group of tremors. ET is the most common neurological cause of action tremor.  Three important tremor syndromes included under this category are enhanced physiological tremor, ET, and cerebellar and psychogenic tremor (PT). Certain uncommon tremor syndromes such as orthostatic tremor, task-specific tremor, Holmes tremor (HT) also present with action tremor.
Enhanced physiological tremor
As the name suggests, physiological tremor occurs in all normal people when muscles are actively used. Physiological tremor is not usually visible to the naked eye because its amplitude is very low. When this tremor becomes visible due to increased sympathetic activity, it is termed as enhanced physiological tremor. Enhanced physiological tremor is the most common cause of a postural tremor. This increased sympathetic activity can be brought about by certain diseases or drugs [Table 2]. ,,,,, The tremor is typically a fine postural or kinetic tremor in the hands and fingers. It is symmetrical and has low amplitude and high frequency (7-12 Hz). , Patients typically give a history of the tremor surfaces only under certain conditions such as stress, fatigue, anxiety, medication use, or caffeine intake. Moreover, such patients do not require to be investigated any further. They improve by removal of the offending agent.
Drug-induced tremor can present as rest or action tremor. The most common form is the enhanced physiological tremor due to drugs [Table 2]. Advancing age and consumption of multiple drugs is a strong risk factor.  Drug-induced postural tremor is symmetrical and has a frequency of 6-8 Hz. , Tardive tremor most commonly presents as postural tremor and can rarely be present at rest. It has a frequency of 3-5 Hz and is of high amplitude. It typically occurs on exposure to neuroleptic (dopamine receptor-blocking agents) drugs and can resemble a Parkinsonian rest tremor. ,, However, it tends to be more symmetrical than Parkinsonian rest tremor.  Usually, this tremor is nonprogressive and responds to drug withdrawal or reduction in dose.
ET is the most common tremor disorder as well as the most common movement disorder described. , It is defined as a symmetrical postural tremor with or without kinetic component that involves hands and forearms lasting for more than 5 years and having a gradual onset and should not be explained by any other underlying disorder.  ET has both components of postural and kinetic tremor, with predominance of one or the other. The amplitude of the kinetic tremor is more than that of the postural component and the kinetic tremor typically increases in amplitude as the target is approached (intention tremor). Age is a risk factor for the development of ET, with the prevalence estimated to be 0.9% in people older than 65 years and increasing to 21.7% in the oldest old. , ET predominantly involves the hands with involvement of upper limbs seen in 95% of the patients.  The typical frequency of the tremor is 5-10 Hz and it tends to be largely symmetrical.  However, it can be asymmetrical and more prominent in the dominant limb.  With the passage of time, typically, the tremor frequency decreases and the amplitude increases.
The tremor in ET may involve other body parts such as voice, head, neck, and legs but not in isolation without the involvement of hands.  Head, voice, and jaw tremors tend to become more prevalent with longer duration of the disease. Important to remember is that if head tremor occurs, then it is a late manifestation of ET; hence, if there is an isolated head tremor in a young patient, then it is likely that he/she has cervical dystonia.  Isolated voice tremor was thought not to be seen in ET, but recent studies have shown that isolated voice tremor may be a spectrum of ET.  One-fourth of patients with ET have a voice tremor. Voice tremor as well as head tremor tends to occur in women and in the older population, suggesting that older age and female sex are defining features of the midline ET symptoms. ,
In severe advanced cases, 20-30% of patients with ET may demonstrate rest tremor.  However, one important clue to differentiate the rest tremor of PD from that of ET is that in the former the rest tremor persists while walking and in the latter it disappears. Presence of isolated rest tremor in the upper limb in the absence of an action tremor is rarely seen in ET, also presence of rest tremor in the legs is extremely rare in patients with ET.  Red flags for the diagnosis of ET are presence of a unilateral tremor, tremor predominantly in the legs, tremor in a hemidistribution, isolated head tremor with posturing, isolated voice tremor, lip tremor, and predominant rest tremor. ET has been considered to be a monosymptomatic disorder, with tremor as its sole feature. However, recent studies have shown that it may not be the case. ET is associated with several other neurological findings, which include cerebellar signs, psychiatric and cognitive disturbances, olfactory and hearing impairments, as well as abnormal sleep patterns. 
Cerebellar tremor is classically defined as an intention tremor, i.e., the tremor that worsens/occurs only on approaching a target. ,, This tremor is of low frequency and variable amplitude. The tremor frequency in the arms is about 3-8 Hz but lower in the legs (1-3 Hz) and trunk (2-4 Hz).  Cerebellar lesions can also produce a postural tremor. , A postural tremor of the head as well as that of the trunk may also be seen. 
Dystonic tremor syndromes
Tremor and dystonia, being one of the common neurological disorders, can coexist in the same patient. Dystonic tremor syndromes can be mistaken for ET or PD and the differentiation from them is given in [Table 3]. Dystonic tremor syndromes are divided into dystonic tremor, tremor associated with dystonia (TAWD), and dystonia-gene associated tremor.  Tremor in dystonia involves most commonly the head or arm, followed by the jaw, facial, or voice tremor and least the legs. 
|Table 3: Differences between essential tremor, Parkinson disease tremor and dystonic tremor|
Click here to view
In dystonic tremor, dystonia as well as tremor (postural/kinetic) is simultaneously present in the same body part, for example, dystonic head tremor.  This tremor is position specific. Dystonic head tremor differs from essential head tremor by being jerky, more pronounced when the head is turned to one side and by its persistence while lying down. It also shows the null point phenomenon, i.e., tremor decreases when placed in the direction of pull. Sensory tricks, neck pain, and hypertrophy of neck muscles are all seen in dystonic head tremor.
Features that favor a dystonic rather than Parkinsonian tremor are task- or position-specific tremor, presence of head tremor, dystonic voice, no evidence of other Parkinsonian features as well as the tremor being thumb extension, rather than the characteristic pill rolling tremor of PD.
Dystonic voice tremor can be differentiated from essential voice tremor by the presence of "geste maneuvers" such as cessation of tremor on changing pitch or singing.
TAWD is characterized by the presence of tremor in one body part and dystonia in another, for example, postural tremor in hands with cervical dystonia. The third type, i.e., dystonia-gene associated tremor is the presence of tremor in a patient who has family history of dystonia. Currently, dystonic tremor and TAWD are clubbed together since they tend to share demographic as well as clinical features. 
Uncommon tremor syndromes
Task-specific tremor occurs predominantly when executing a specific and a skilled task that is not associated with an abnormal posturing. , Primary writing tremor is considered to be the most common of these.  It can be associated with postural and intention tremor. The tremor is a pronation/supination that occurs at the wrist joint.  The frequency of this writing tremor is between 4 and 8 Hz.  It has been classified into two types depending upon whether the tremor occurs during the actual task of writing (type A, task-induced) or when the hand adopts a writing posture (type B, position-specific).  Other examples of task-specific tremor are voice tremor, golfers tremor, laughing tremor, tremor in musicians, and other trained professionals. ,
Orthostatic tremor is a rare, high-frequency symmetrical tremor of 13-16 Hz involving the legs and trunk. It occurs more commonly in women and is typically seen in the sixth to seventh decade. , It presents exclusively on standing, decreases on walking, and altogether disappears on sitting or lying down. , Patients may only complain of having poor balance while standing and assuming a wide base, which gets relieved on walking. Although classically described in the legs and trunk, it may also be seen in the arms, especially on weight bearing and also in the jaw.  This tremor may be visible as a fine ripple or palpable or could be heard via a stethoscope placed over the thigh or calf muscles, which produces a thumping sound resembling the sound of a helicopter. , HT is a rare tremor affecting the proximal parts of the limbs. It has been called by various names, which include rubral and mid-brain tremor. This tremor is typically present at rest and worsens on posture and movement. It has a low frequency (2-5 Hz) and high amplitude. A lesion in the thalamus, upper brainstem, or cerebellum can cause HT. , It is important to differentiate the rest tremor of HT from that of PD. In HT, the rest tremor has a frequency of <4 Hz and involves proximal part of the limbs whereas PD causes the classic pill-rolling tremor of 4-6 Hz involving the limbs distally.  Thalamic tremor occurs due to involvement of dorsolateral part of the thalamus and resembles HT. The differentiating feature is the presence of associated dystonia. HT should also be differentiated from myorhythmia, which is a slow (1-4 Hz) rhythmic movement mainly affecting the cranial or limb muscles. Typically, HT does not involve cranial muscles and has higher amplitude. Myorhythmia presents mainly at rest, whereas HT occurs as rest and kinetic tremor.
Wilson disease is an important treatable cause of action tremor before the age of 40. , All types of tremor are seen, but rest and/or postural tremor are the most common.  A very characteristic form of tremor in Wilson disease is the proximal "wing beating" pattern, which is brought out by placing the arms abducted with elbows flexed. Neuropathic tremor develops in patients with demyelinating peripheral neuropathy.  These tremors are usually postural or kinetic and occur in hands/arms which may be symmetrical or asymmetrical. Their frequency ranges from 3 to 6 Hz. ,
Among all the psychogenic movement disorders (PMDs), tremor is the most common. It makes up 50% of all PMDs.  PT is characterized by the presence of rest, postural, or kinetic tremor, but most often all three types are seen in unison.  The tremor characteristically starts in both arms spreading to involve the head and legs.  Diagnosis of PT relies on history and clinical examination. Tremor that is of abrupt onset, with changing characteristics, is suggestive of PT. Excluding other organic tremors to reach a diagnosis of PT is not sufficient enough, demonstrating certain signs which are compatible with PT is essential [Table 4]. These signs, especially entrainment, coherence, and coactivation, can also be objectively recorded using surface electromyography (EMG) and accelerometer.
| Clinical Approach to Tremor|| |
What do you see?
The first step in managing a patient with any movement disorder is to correctly identify the type of abnormal movement, which may be involuntary or voluntary (psychogenic). Involuntary movements are often nonsuppressible (tremor and myoclonus), but some can be partially suppressed (tics and stereotypy). Key feature that sets tremor apart from other movements is the rhythmicity, i.e., the oscillations occur at a regular frequency. Chorea, ballismus, and tics have a jerky component not seen in tremor. Rhythmic myoclonus, which includes epilepsia partialis continua and cortical tremor, can mimic tremor.  Clonus which occurs on passive stretching of joints could also be confused for tremor.
Clues in history
Once the movement has been recognized as tremor, the most important step is to establish the etiology. To do so, a stepwise systematic approach has to be adopted, and taking a good history is the first step. Age at onset could provide vital information. ET has a bimodal peak, whereas orthostatic tremor and PD occur in older age group. An acute onset would suggest a vascular event, tumor, cerebellitis, demyelinating lesion, toxin, or psychogenic origin. A slowly progressive tremor is more likely to be ET or PD. A symmetrical tremor is more likely to be due to ET or physiological tremor. Asymmetry is the hallmark of PD as well as an acute vascular event or tumors. As outlined, above drugs are capable of causing all forms of tremor; however, they tend to be symmetrical most often. Tremor exclusively brought about by fatigue, exercise, or caffeine could be enhanced physiological tremor, and just reassurance should be sufficient.
Examination of rest and action tremor
Observing the patient as he walks into a room and is seated could be very helpful. The patient may even be anxious enough in the beginning of the examination, which would bring out his rest tremor. Most tremors of clinical significance have a frequency range of 4-12 Hz.  The frequency range of rest tremor is 3-6 Hz and that of postural tremor is 4-12 Hz, and for kinetic tremor, it is 2-7 Hz in most instances [Table 1].  Subjecting the patient to stressful maneuvers could help in bringing out the subtle rest tremor [Table 5]. Action tremor is present during voluntary activity and when the limb in question is put into action [Table 5]. Spiral drawing could help differentiate between ET, DT, and PD [Figure 2]. Task-specific tremor is obvious during particular tasks such as primary writing tremor and voice tremor, which can be brought out by asking the patient to hold a long note.
|Figure 2: Archimedes spirals drawn by a normal volunteer and patients with Parkinson's disease, essential tremor, and dystonic tremor. A small spiral (micrographia) occurs in Parkinson's disease; whereas, in essential tremor, moderate amplitude of oscillations is present throughout the task. The spiral drawing in a dystonic tremor patient is showing a directional preponderance, which suggests the same muscle groups are constantly involved|
Click here to view
General physical and neurological examination
Before going to the neurological examination, it is important to look for some clues in the general physical examination. Tachycardia, neck swelling, and eye signs could suggest hyperthyroidism. Signs of liver dysfunction and chronic alcoholism should be noted.
A thorough neurological examination starting from the cranial nerves to gait is necessary.
Eye movement abnormalities are seen in cerebellar disorders and Parkinsonian syndromes. Any patient presenting with action tremor before 40 years should be examined for Kayser-Fleischer ring in the cornea to rule out Wilson's disease. Rigidity, especially cogwheeling and bradykinesia, should be looked for in all patients who present with a rest tremor. Eliciting intentional component of the tremor localizes the pathology to the cerebellum.
Examining the gait could also help in diagnosing the cause of the tremor with normal gait seen in ET and characteristic gait observed in cerebellar disorders or PD.
Tests for chronic liver disease, thyroid function tests, serum ceruloplasmin, and 24-h urine copper and toxin screen should be done.  Magnetic resonance imaging (MRI) of the brain is indicated when a patient presents with acute onset intention tremor. It is, however, not indicated routinely in all patients.
Since structural neuroimaging would be normal in the early stages of PD, [ 18 F]-labeled L-3,4-dihydroxiphenylalanine positron emission tomography imaging is considered to be the best diagnostic modality and it also helps differentiate it from other Parkinsonian syndromes as well as ET. ,, Dopamine transporter single-photon emission computerized tomography could also be used for this purpose. The dopamine striatal neurotransmission in patients with ET, PT, and drug-induced tremor is normal. 
Assessment of tremor
Clinical rating scales
There are different ways to measure tremor, which includes either using a clinical rating scale or transducers-based measurement. The former is still popular, but the major drawback when compared to the electrophysiological analysis is that these cannot quantify the tremor in terms of frequency and amplitude. The current approved scales by MDS for tremor severity assessment are given in [Table 6]. 
Transducer-based measurements to quantify and characterize tremor include surface EMG, accelerometer, digitizing tablet-based measures, and several others. These transducers are especially useful in monitoring the disease progression as well as in noting the response to treatment.  Accelerometer, gyroscope, and surface EMG are equally good in assessing the tremor frequency; however, for measuring amplitude, only the former two transducers are good. 
Surface EMG is done using skin electrodes that are placed over muscle bellies. Surface EMG helps in identifying pathological tremor as well as in quantifying them [Table 5]. The majority of the healthy people with physiological tremor show no rhythmic EMG activity, which differentiates it from organic tremor. 
It is the most common method used to electronically evaluate a tremor.  It is considered the gold standard in quantifying tremor amplitude.  A change in tremor frequency noted on accelerometer rather than amplitude is more suggestive of PT as organic tremors may also show change in amplitude [Table 7]. ,,,,,,,,
Gyroscopic transducers are similar to accelerometers, but they measure angular acceleration compared to the linear acceleration measured by latter.  They are also useful in quantifying pathological tremor in terms of amplitude and frequency.  Actigraphs can be worn on the wrist and is the size of a watch. It can measure the tremor amplitude and frequency over prolonged periods and during various activities.  It can also be used to detect the presence of pathological tremor as well as to monitor the change in amplitude with treatment. 
Although accelerometer quantifies the postural tremor, the main disability in is the task-related kinetic tremor in ET. Spiral drawing and handwriting are useful tasks that can be performed and graded visually. Digitizing tablets are one-way to quantify the writing and drawing of a patient with tremor.  These devices, however, are unable to detect physiological tremor and mild organic tremor. These devices can quantify tremor severity but cannot differentiate between the various types of pathological tremors. 
Force sensors estimate the amount of joint movement, which is especially useful in the hands as it can give valuable information regarding the muscles involved. This in turn can be utilized in planning botulinum toxin injections. 
| Treatment|| |
The treatment of tremor is symptomatic. It can be treated with medications, botulinum toxin, or surgery.
The medical treatment of tremor not only depends on the underlying disorder but also depends on how disabled the patient is due to the tremor.  The current treatment recommendation for postural limb tremor in ET is with propranolol or primidone as both these drugs reduce tremor amplitude by 50%. , Both these drugs are known to be efficacious for a year at least after starting treatment.  However, their long-term effects are unknown.  In nearly one-third to one-half of patients, these drugs fail to produce a response.  Drugs that are emerging as alternative therapy and could be effective for postural limb tremor in ET are topiramate, gabapentin, and clonazepam.  A trial of other beta blockers such as metoprolol, atenolol, sotalol, and nadolol can also be given, but none have them have been found to be superior to propranolol.  Insufficient evidence exists for diazepam, lorazepam, levetiracetam, pregabalin, zonisamide, tiagabine, sodium oxybate, phenobarbitone, flunarizine, and amantadine in the management of essential limb tremor. 
Recently, it was shown that long-chain alcohol, 1-octanol, could be effective in treating limb tremor in ET.  Parkinsonian rest tremor is treated with dopamine agonists and anticholinergics. Propranolol and clonazepam may benefit patients with neuropathic tremor, cerebellar tremor, and tremor seen in MS.  Gabapentin and clonazepam are useful in managing orthostatic tremor.  HT is difficult to treat, but a trial of clonazepam, trihexyphenidyl, or levodopa can be given. ,
Botulinum toxin benefits those patients who have tremor involving head, jaw, voice, and chin.  Its benefits in arm tremor are limited, and efficacy is modest, the side effect of wrist/finger weakness being the limiting factor.  However, botulinum toxin improves the clinical rating scale in patients with essential hand tremor. Therefore, it is recommended in patients with essential hand tremor that are of large amplitude, disabling, and refractory to medical treatment. Primary writing tremor shows good response to botulinum toxin.  Botulinum toxin is considered treatment of choice in dystonic head tremor also. 
Deep brain stimulation and focused ultrasound
Deep brain stimulation (DBS) could be effective in Parkinsonian rest tremor, HT, dystonic tremor, and cerebellar tremor but is most commonly used to treat ET. ,
As already mentioned, nearly half of the patients with ET do not respond to medical management. DBS of the thalamic nucleus ventrointermedius (VIM) decreases tremor by 90% and should be considered in patients who do not respond to medical therapy and are severely disabled.  The treatment of ET with DBS produces significant response in the upper limbs, voice, and head tremor.  The long-term efficacy of DBS in ET has recently been shown, but the possibility of tolerance to DBS has to be kept in mind in patients with long-term stimulation.  Thus, DBS is a safe and effective treatment for patients with disabling ET. 
Dystonic tremor (axial/appendicular) tends to be medically refractory, and DBS is a good option in these patients with improvement seen in nearly 50-80% cases.  The target for DBS in DT is uncertain with reports suggesting the sites could be VIM, globus pallidus internus, as well as caudal zona incerta.  DBS can produce side effects; however, in patients in whom all other treatments have failed, this could be a good option.
Recently, the use of transcranial MRI-guided focused ultrasound has been popularized for ET. The target site is the ventral intermediate nucleus of the thalamus. The procedure improves the hand tremor scores. It is a safe and a noninvasive procedure and can be especially considered in the treatment of disabling drug-resistant ET. 
| Conclusion|| |
Tremor is a common neurological condition encountered in clinical practice. Although the symptoms are minor in the majority of the patients, they can be disabling as well as resistant to treatment in some. An approach based on the phenomenological classification of tremor divides them broadly into rest and action tremor. This classification is useful since it helps in narrowing down the differential diagnosis. Although ET is the most common neurological cause of tremor, enhanced physiological tremor should always be kept in mind especially if the symptoms are brought about under certain circumstances. Parkinsonian tremor is the most common cause of rest tremor, but other causes especially long-term exposure to dopamine receptor-blocking drugs should always be ruled out.
Treatment of tremor is usually symptomatic. Propranolol, primidone, and topiramate are most commonly used for treatment in ET patients. New and upcoming therapies such as DBS and focused ultrasound could help manage patients with severe debilitating and drug-resistant ET. Botulinum toxin is the treatment of choice in primary writing tremor and dystonic tremor.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Deuschl G, Bain P, Brin M. Consensus statement of the movement disorder society on tremor. Ad Hoc Scientific Committee. Mov Disord 1998;13 Suppl 3:2-23.
Bain PG. Parkinsonism and related disorders. Tremor. Parkinsonism Relat Disord 2007;13 Suppl 3:S369-74.
Bhidayasiri R. Differential diagnosis of common tremor syndromes. Postgrad Med J 2005;81:756-62.
Leehey MA. Tremor: Diagnosis and treatment. Prim Care Case Rev 2001;4:32-9.
Puschmann A, Wszolek ZK. Diagnosis and treatment of common forms of tremor. Semin Neurol 2011;31:65-77.
Gövert F, Deuschl G. Tremor entities and their classification: An update. Curr Opin Neurol 2015;28:393-9.
Schneider SA, Deuschl G. Medical and surgical treatment of tremors. Neurol Clin 2015;33:57-75.
Hess CW, Pullman SL. Tremor: Clinical phenomenology and assessment techniques. Tremor Other Hyperkinet Mov (N Y) 2012;2. pii: tre-02-65-365-1.
Edwards MJ, Deuschl G. Tremor syndromes. Continuum (Minneap Minn) 2013;19:1213-24.
Elble RJ, Koller WC. Tremor. Baltimore: The Johns Hopkins University Press; 1990.
Crawford P, Zimmerman EE. Differentiation and diagnosis of tremor. Am Fam Physician 2011;83:697-702.
Jankovic J. Parkinson's disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-76.
Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:646-50.
Habib-Ur-Rehman. Diagnosis and management of tremor. Arch Intern Med 2000;160:2438-44.
Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534-41.
Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, et al.
Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study. Mov Disord 2002;17:782-8.
Zheng HG, Zhang R, Li X, Li FF, Wang YC, Wang XM, et al.
Heterogeneity of monosymptomatic resting tremor in a prospective study: Clinical features, electrophysiological test, and dopamine transporter positron emission tomography. Chin Med J (Engl) 2015;128:1765-71.
Schwingenschuh P, Ruge D, Edwards MJ, Terranova C, Katschnig P, Carrillo F, et al.
Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study. Mov Disord 2010;25:560-9.
Thanvi B, Treadwell S. Drug induced parkinsonism: A common cause of parkinsonism in older people. Postgrad Med J 2009;85:322-6.
Alty JE, Kempster PA. A practical guide to the differential diagnosis of tremor. Postgrad Med J 2011;87:623-9.
Brin MF, Koller W. Epidemiology and genetics of essential tremor. Mov Disord 1998;13 Suppl 3:55-63.
Quinn NP, Schneider SA, Schwingenschuh P, Bhatia KP. Tremor - some controversial aspects. Mov Disord 2011;26:18-23.
Deuschl G, Wenzelburger R, Löffler K, Raethjen J, Stolze H. Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Brain 2000;123(Pt 8):1568-80.
Whaley NR, Putzke JD, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: Phenotypic expression in a clinical cohort. Parkinsonism Relat Disord 2007;13:333-9.
Deuschl G, Elble R. Essential tremor - neurodegenerative or nondegenerative disease towards a working definition of ET. Mov Disord 2009;24:2033-41.
Lou JS, Jankovic J. Essential tremor: Clinical correlates in 350 patients. Neurology 1991;41:234-8.
Patel A, Frucht SJ. Isolated vocal tremor as a focal phenotype of essential tremor: A retrospective case review. J Clin Mov Disord 2015;2:4.
Louis ED. When do essential tremor patients develop head tremor? Influences of age and duration and evidence of a biological clock. Neuroepidemiology 2013;41:110-5.
Louis ED, Ford B, Lee H, Andrews H, Cameron G. Diagnostic criteria for essential tremor: A population perspective. Arch Neurol 1998;55:823-8.
Louis ED, Thawani SP, Andrews HF. Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, N. Y. Neuroepidemiology 2009;32:208-14.
Defazio G, Conte A, Gigante AF, Fabbrini G, Berardelli A. Is tremor in dystonia a phenotypic feature of dystonia? Neurology 2015;84:1053-9.
Pandey S, Sarma N. Tremor in dystonia. Parkinsonism Relat Disord 2016. pii: S1353-802030078-5.
Rothwell JC, Traub MM, Marsden CD. Primary writing tremor. J Neurol Neurosurg Psychiatry 1979;42:1106-14.
Bain PG, Findley LJ, Britton TC, Rothwell JC, Gresty MA, Thompson PD, et al.
Primary writing tremor. Brain 1995;118(Pt 6):1461-72.
Britton TC, Thompson PD, van der Kamp W, Rothwell JC, Day BL, Findley LJ, et al.
Primary orthostatic tremor: Further observations in six cases. J Neurol 1992;239:209-17.
Bain PG, Britton TC, Jenkins IH, Thompson PD, Rothwell JC, Thomas PK, et al.
Tremor associated with benign IgM paraproteinaemic neuropathy. Brain 1996;119(Pt 3):789-99.
Edwards MJ, Bhatia KP. Functional (psychogenic) movement disorders: Merging mind and brain. Lancet Neurol 2012;11:250-60.
Grimaldi G, Manto M. Tremor: From Pathogenesis to Treatment. San Rafael, CA, USA: Morgan and Claypool; 2008.
Antonini A, Moresco RM, Gobbo C, De Notaris R, Panzacchi A, Barone P, et al.
The status of dopamine nerve terminals in Parkinson's disease and essential tremor: A PET study with the tracer [11-C] FE-CIT. Neurol Sci 2001;22:47-8.
Isaias IU, Marotta G, Hirano S, Canesi M, Benti R, Righini A, et al.
Imaging essential tremor. Mov Disord 2010;25:679-86.
Elble R, Bain P, Forjaz MJ, Haubenberger D, Testa C, Goetz CG, et al.
Task force report: Scales for screening and evaluating tremor: Critique and recommendations. Mov Disord 2013;28:1793-800.
Grimaldi G, Manto M. Neurological tremor: Sensors, signal processing and emerging applications. Sensors (Basel) 2010;10:1399-422.
Elble RJ. Characteristics of physiologic tremor in young and elderly adults. Clin Neurophysiol 2003;114:624-35.
Andrade AO, Pereira AA, Paixão AP, Cavalheiro GL, de Almeida MF, Fenelon SB, et al
. Human Tremor: Origins, Detection and Quantification. Croatia:INTECH Open Access Publisher; 2013.
Elble RJ, Pullman SL, Matsumoto JY, Raethjen J, Deuschl G, Tintner R. Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain 2006;129(Pt 10):2660-6.
Haubenberger D, Abbruzzese G, Bain PG, Bajaj N, Benito-León J, Bhatia KP, et al.
Transducer-based evaluation of tremor. Mov Disord 2016. [Epub ahead of print].
Zeuner KE, Shoge RO, Goldstein SR, Dambrosia JM, Hallett M. Accelerometry to distinguish psychogenic from essential or Parkinsonian tremor. Neurology 2003;61:548-50.
Elble RJ. Characteristics of physiologic tremor in young and elderly adults. Clin Neurophysiol 2003;114:624-35.
Hallett M. Physiology of psychogenic movement disorders. J Clin Neurosci 2010;17:959-65.
Klapp ST, Hill MD, Tyler JG, Martin ZE, Jagacinski RJ, Jones MR. On marching to two different drummers: Perceptual aspects of the difficulties. J Exp Psychol Hum Percept Perform 1985;11:814-27.
Deuschl G, Köster B, Lücking CH, Scheidt C. Diagnostic and pathophysiological aspects of psychogenic tremors. Mov Disord 1998;13:294-302.
Louis ED, Pullman SL. Comparison of clinical vs. electrophysiological methods of diagnosing of essential tremor. Mov Disord 2001;16:668-73.
Journee HL, Postma AA, Staal MJ. Intraoperative neurophysiological assessment of disabling symptoms in DBS surgery. Neurophysiol Clin 2007;37:467-75.
Haubenberger D, Kalowitz D, Nahab FB, Toro C, Ippolito D, Luckenbaugh DA, et al.
Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor. Mov Disord 2011;26:2073-80.
Schneider SA, Deuschl G. The treatment of tremor. Neurotherapeutics 2014;11:128-38.
Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr., et al.
Evidence-based guideline update: Treatment of essential tremor: Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2011;77:1752-5.
Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurol 2011;10:148-61.
Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB Jr., et al.
Practice parameter: Therapies for essential tremor: Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2005;64:2008-20.
Haubenberger D, Nahab FB, Voller B, Hallett M. Treatment of essential tremor with long-chain alcohols: Still experimental or ready for prime time? Tremor Other Hyperkinet Mov (N Y) 2014;4. pii: tre-04-211-4673-2.
Evidente VG, Adler CH, Caviness JN, Gwinn KA. Effective treatment of orthostatic tremor with gabapentin. Mov Disord 1998;13:829-31.
Boelmans K, Gerloff C, Münchau A. Long-lasting effect of levodopa on Holmes' tremor. Mov Disord 2012;27:1097-8.
Schneider SA, Edwards MJ, Cordivari C, Macleod WN, Bhatia KP. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease. Mov Disord 2006;21:1722-4.
Papapetropoulos S, Singer C. Treatment of primary writing tremor with botulinum toxin type a injections: Report of a case series. Clin Neuropharmacol 2006;29:364-7.
Lyons KE, Pahwa R. Deep brain stimulation and tremor. Neurotherapeutics 2008;5:331-8.
Baizabal-Carvallo JF, Kagnoff MN, Jimenez-Shahed J, Fekete R, Jankovic J. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry 2014;85:567-72.
Hedera P, Phibbs FT, Dolhun R, Charles PD, Konrad PE, Neimat JS, et al.
Surgical targets for dystonic tremor: Considerations between the globus pallidus and ventral intermediate thalamic nucleus. Parkinsonism Relat Disord 2013;19:684-6.
Lipsman N, Schwartz ML, Huang Y, Lee L, Sankar T, Chapman M, et al.
MR-guided focused ultrasound thalamotomy for essential tremor: A proof-of-concept study. Lancet Neurol 2013;12:462-8.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7]
|This article has been cited by|
||Head tremor in cervical dystonia: Quantifying severity with computer vision
| ||JeanneP. Vu, Elizabeth Cisneros, Ha Yeon Lee, Linh Le, Qiyu Chen, Xiaoyan A. Guo, Ryin Rouzbehani, Joseph Jankovic, Stewart Factor, Christopher G. Goetz, Richard L. Barbano, Joel S. Perlmutter, H.A. Jinnah, Sarah Pirio Richardson, Glenn T. Stebbins, Rodger Elble, Cynthia L. Comella, David A. Peterson |
| ||Journal of the Neurological Sciences. 2022; : 120154 |
|[Pubmed] | [DOI]|
||Tremor and Rigidity in Patients with Parkinsonís Disease: Emphasis on
Epidemiology, Pathophysiology and Contributing Factors
| ||Shivam Kumar, Lav Goyal, Shamsher Singh |
| ||CNS & Neurological Disorders - Drug Targets. 2022; 21(7): 596 |
|[Pubmed] | [DOI]|
||Imaging Tremor Quantification for Neurological Disease Diagnosis
| ||Yuichi Mitsui, Thi Thi Zin, Nobuyuki Ishii, Hitoshi Mochizuki |
| ||Sensors. 2020; 20(22): 6684 |
|[Pubmed] | [DOI]|
||Quantitative assessment of Parkinsonian tremor by using biosensor device
| ||Silvia Marino, Emanuele Cartella, Nicola Donato, Nunzio Muscarŗ, Chiara Sorbera, Vincenzo Cimino, Simona De Salvo, Katia Micchža, Giuseppe Silvestri, Alessia Bramanti, Giuseppe Di Lorenzo |
| ||Medicine. 2019; 98(51): e17897 |
|[Pubmed] | [DOI]|